News & Blog

Neuroservice and MaxWell Biosystems announce strategic partnership

Neuroservice and MaxWell Biosystems announce strategic partnership to develop HD-MEA assays for human iPSC-derived neurons and other cell cultures Aix-en-Provence, FRANCE and Zurich, SWITZERLAND – October 28, 2020. Today, Neuroservice and MaxWell Biosystems are thrilled to announce a strategic partnership aiming to provide the pharmaceutical industry with a new state-of-the-art CNS in vitro cell electrophysiological solution based on high-density microelectrode array recording of human iPSC-derived neurons and other neuron cultures. The partnership will combine the MaxTwo high-density microelectrode array (HD-MEA)…

MaxWell Monthly Must-Reads (October 2020)

  It is already time for the 10th edition of our monthly blog. We hope you enjoyed last month’s post about microelectrode array (MEA) technology for drug screening as well as our previous posts about a variety of scientific topics (Beta Cells, Burst Detection, Axons, Retina, Organoids, Human iPSC-Derived Neurons, Neurons and Viruses and Spike Sorting). In our October edition, we highlight the latest developments on Neuroengineering, with a focus on development of technologies for manipulating neural networks. We highlighted the article written by Kim et al. which describes a…

MaxWell Biosystems appoints Dr. Marcel Suter as new VP Operations

Zurich, Switzerland – September 30, 2020 MaxWell Biosystems AG is pleased to announce the appointment of Dr. Marcel Suter as the new Vice President of Operations, effective September 1, 2020. In this new position, Dr. Suter will oversee the company’s operational units, including, supply chain, production, logistics, procurement, and quality control. He will report directly to Dr. Urs Frey, CEO. With more than eight years of experience as project manager and as VP Operations at Optotune, an optics company, Dr.…

Capture the activity of thousands of communicating neurons all at once

Latest Neurochip published in Nature Communications Today, a new generation of high-density microelectrode array (HD-MEA) technology has been published in Nature Communications (link). This publication not only demonstrates the excellent performance of the chip, but also describes the large-scale extraction of neuronal metrics, such as axonal conduction velocity, and includes impressive showcases of applications with various neuronal preparations. The developed versatile platform for label-free, live-cell electrical imaging will further accelerate drug discovery and basic research in the field of neuroscience.…

MaxWell Monthly Must-Reads (September 2020)

  It is time for the 9th edition of our monthly blog. Earlier this year, we have highlighted each month five papers dealing wiht a variety of scientific applications –Beta Cells, Burst Detection , Axons, Retina, Organoids and Human iPSC-Derived Neurons – as well as with a topic closely related to our daily operations, Spike Sorting. During the COVID-19 lockdown in April we published a special edition about Neurons and Viruses. In our September edition we highlight the use of Microelectrode array (MEA) technology for drug screening.…
Contacts






Albisriederstrasse 253
8047 Zurich, Switzerland

+41 44 244 24 24

info@mxwbio.com